4-1002713-GCCC-GCCCCC
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_000203.5(IDUA):c.1190-11_1190-10dupCC variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000409 in 1,363,574 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0013 ( 2 hom., cov: 29)
Exomes 𝑓: 0.00030 ( 0 hom. )
Consequence
IDUA
NM_000203.5 intron
NM_000203.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.792
Genes affected
IDUA (HGNC:5391): (alpha-L-iduronidase) This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 4-1002713-G-GCC is Benign according to our data. Variant chr4-1002713-G-GCC is described in ClinVar as [Benign]. Clinvar id is 1600766.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00128 (192/149760) while in subpopulation AFR AF = 0.00373 (152/40706). AF 95% confidence interval is 0.00325. There are 2 homozygotes in GnomAd4. There are 90 alleles in the male GnomAd4 subpopulation. Median coverage is 29. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00129 AC: 193AN: 149662Hom.: 2 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
193
AN:
149662
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000738 AC: 54AN: 73188 AF XY: 0.000916 show subpopulations
GnomAD2 exomes
AF:
AC:
54
AN:
73188
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000302 AC: 366AN: 1213814Hom.: 0 Cov.: 24 AF XY: 0.000333 AC XY: 200AN XY: 601188 show subpopulations
GnomAD4 exome
AF:
AC:
366
AN:
1213814
Hom.:
Cov.:
24
AF XY:
AC XY:
200
AN XY:
601188
Gnomad4 AFR exome
AF:
AC:
27
AN:
24082
Gnomad4 AMR exome
AF:
AC:
5
AN:
29050
Gnomad4 ASJ exome
AF:
AC:
7
AN:
22404
Gnomad4 EAS exome
AF:
AC:
5
AN:
28868
Gnomad4 SAS exome
AF:
AC:
125
AN:
67350
Gnomad4 FIN exome
AF:
AC:
4
AN:
32706
Gnomad4 NFE exome
AF:
AC:
172
AN:
954808
Gnomad4 Remaining exome
AF:
AC:
19
AN:
50936
⚠️ The allele balance in gnomAD4 Exomes is highly skewed (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Heterozygous variant carriers
0
34
69
103
138
172
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00128 AC: 192AN: 149760Hom.: 2 Cov.: 29 AF XY: 0.00123 AC XY: 90AN XY: 73090 show subpopulations
GnomAD4 genome
AF:
AC:
192
AN:
149760
Hom.:
Cov.:
29
AF XY:
AC XY:
90
AN XY:
73090
Gnomad4 AFR
AF:
AC:
0.00373409
AN:
0.00373409
Gnomad4 AMR
AF:
AC:
0.000395831
AN:
0.000395831
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0.000596421
AN:
0.000596421
Gnomad4 SAS
AF:
AC:
0.00106022
AN:
0.00106022
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000342272
AN:
0.000342272
Gnomad4 OTH
AF:
AC:
0.000967118
AN:
0.000967118
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Mucopolysaccharidosis type 1 Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at